173 related articles for article (PubMed ID: 17090657)
1. CD34 cells from patients with trisomy 8 myelodysplastic syndrome (MDS) express early apoptotic markers but avoid programmed cell death by up-regulation of antiapoptotic proteins.
Sloand EM; Pfannes L; Chen G; Shah S; Solomou EE; Barrett J; Young NS
Blood; 2007 Mar; 109(6):2399-405. PubMed ID: 17090657
[TBL] [Abstract][Full Text] [Related]
2. Growth advantage of CD34+ cells in trisomy 8 high-risk myelodysplastic syndrome despite enhanced apoptotic signals.
Youssef SR; Ismail MM; Abd Al Wahed E; Al Dessoky H
East Mediterr Health J; 2012 Oct; 18(10):1065-71. PubMed ID: 23301363
[TBL] [Abstract][Full Text] [Related]
3. Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities.
Chen G; Zeng W; Miyazato A; Billings E; Maciejewski JP; Kajigaya S; Sloand EM; Young NS
Blood; 2004 Dec; 104(13):4210-8. PubMed ID: 15315976
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation.
Hopfer O; Komor M; Koehler IS; Schulze M; Hoelzer D; Thiel E; Hofmann WK
Exp Hematol; 2007 May; 35(5):712-23. PubMed ID: 17577921
[TBL] [Abstract][Full Text] [Related]
5. Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes.
Gianelli U; Fracchiolla NS; Cortelezzi A; Pellegrini C; Savi F; Moro A; Grimoldi MG; Deliliers GL; Coggi G; Bosari S
Ann Hematol; 2007 Mar; 86(3):185-9. PubMed ID: 17124585
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of TET2 in CD3⁺ and CD34⁺ cells of myelodysplastic syndromes and enhances CD34⁺ cells proliferation.
Zhang W; Shao Z; Fu R; Wang H; Li L; Liu H
Int J Clin Exp Pathol; 2015; 8(9):10840-6. PubMed ID: 26617797
[TBL] [Abstract][Full Text] [Related]
7. Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells.
Rajapaksa R; Ginzton N; Rott LS; Greenberg PL
Blood; 1996 Dec; 88(11):4275-87. PubMed ID: 8943864
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of apoptosis protein inhibitor survivin and XIAP, in patients with myelodysplastic syndromes and in the cell line MUTZ-1].
Cai Z; Bao HY; Ludwig WD; Wuchter C
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):26-30. PubMed ID: 14990073
[TBL] [Abstract][Full Text] [Related]
9. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.
Nilsson L; Astrand-Grundström I; Anderson K; Arvidsson I; Hokland P; Bryder D; Kjeldsen L; Johansson B; Hellström-Lindberg E; Hast R; Jacobsen SE
Blood; 2002 Jul; 100(1):259-67. PubMed ID: 12070035
[TBL] [Abstract][Full Text] [Related]
10. The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.
Li X; Marcondes AM; Gooley TA; Deeg HJ
Blood; 2010 Sep; 116(13):2304-14. PubMed ID: 20562331
[TBL] [Abstract][Full Text] [Related]
11. Programmed cell death is an intrinsic feature of MDS progenitors, predominantly found in the cluster-forming cells.
Span LF; Vierwinden G; Pennings AH; Boezeman JB; Raymakers RA; de Witte T
Exp Hematol; 2005 Apr; 33(4):435-42. PubMed ID: 15781334
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis in human myelodysplastic syndrome CD34+ cells is modulated by the upregulation of TLRs and histone H4 acetylation via a β-arrestin 1 dependent mechanism.
Zeng Q; Shu J; Hu Q; Zhou SH; Qian YM; Hu MH; Hu LY; Wang YG; Zhou YM; Lu JH
Exp Cell Res; 2016 Jan; 340(1):22-31. PubMed ID: 26708616
[TBL] [Abstract][Full Text] [Related]
13. Recurrent Abnormal Clones in Myelodysplastic Syndrome Marrow Originate from Cells at a Pluripotent Stem Level and Maintain Their Early Differentiation Potency.
Qi H; Qingxia Z; Xiao L; Lingyun W; Feng X; Zheng Z; Chunkang C
Cancer Invest; 2015; 33(8):369-77. PubMed ID: 26135215
[TBL] [Abstract][Full Text] [Related]
14. Fas-mediated apoptosis is important in regulating cell replication and death in trisomy 8 hematopoietic cells but not in cells with other cytogenetic abnormalities.
Sloand EM; Kim S; Fuhrer M; Risitano AM; Nakamura R; Maciejewski JP; Barrett AJ; Young NS
Blood; 2002 Dec; 100(13):4427-32. PubMed ID: 12393649
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor-4 is up-regulated in hematopoietic progenitor cells and contributes to increased apoptosis in myelodysplastic syndromes.
Maratheftis CI; Andreakos E; Moutsopoulos HM; Voulgarelis M
Clin Cancer Res; 2007 Feb; 13(4):1154-60. PubMed ID: 17317824
[TBL] [Abstract][Full Text] [Related]
16. T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy.
Sloand EM; Melenhorst JJ; Tucker ZC; Pfannes L; Brenchley JM; Yong A; Visconte V; Wu C; Gostick E; Scheinberg P; Olnes MJ; Douek DC; Price DA; Barrett AJ; Young NS
Blood; 2011 Mar; 117(9):2691-9. PubMed ID: 21097671
[TBL] [Abstract][Full Text] [Related]
17. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
18. Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na.
Olnes MJ; Shenoy A; Weinstein B; Pfannes L; Loeliger K; Tucker Z; Tian X; Kwak M; Wilhelm F; Yong AS; Maric I; Maniar M; Scheinberg P; Groopman J; Young NS; Sloand EM
Leuk Res; 2012 Aug; 36(8):982-9. PubMed ID: 22524974
[TBL] [Abstract][Full Text] [Related]
19. 'Low-risk' myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro- versus anti-apoptotic bcl-2-related proteins.
Parker JE; Fishlock KL; Mijovic A; Czepulkowski B; Pagliuca A; Mufti GJ
Br J Haematol; 1998 Dec; 103(4):1075-82. PubMed ID: 9886323
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrow.
Pecci A; Travaglino E; Klersy C; Invernizzi R
Acta Haematol; 2003; 109(1):29-34. PubMed ID: 12486320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
